Core Viewpoint - The company, Puluo Pharmaceutical Co., Ltd., has received a notice from its controlling shareholder, Hengdian Group Holdings Co., Ltd., regarding the increase in shareholding by its concerted action party, Dongyang Hengdian Yushan Sports Leisure Co., Ltd. This increase has brought the total shareholding of the controlling shareholder and its concerted action parties to 52.03% [2][4]. Group 1: Shareholding Changes - On January 13, 2026, Yushan Sports increased its shareholding by 1,653,500 shares, accounting for 0.14% of the company's total share capital, with a total investment of RMB 28,695,970 [2][4]. - Prior to this increase, Yushan Sports held 9,241,603 shares, representing 0.80% of the total share capital, while the total shareholding of the controlling shareholder and its concerted action parties was 51.89% [3][4]. Group 2: Future Shareholding Plans - Yushan Sports plans to increase its shareholding by an amount not less than RMB 60 million and not exceeding RMB 120 million within six months from January 13, 2026 [2][4]. - The increase will be executed through centralized bidding on the Shenzhen Stock Exchange, without a set price range, considering the intrinsic value of the stock and market trends [4][5]. Group 3: Funding and Commitments - The funds for the share purchase will come from Yushan Sports' own or raised funds [6]. - Yushan Sports has committed not to reduce its shareholding during the implementation period of the increase plan and will adhere to relevant regulations [6][10]. Group 4: Regulatory Compliance - The shareholding increase will not affect the company's compliance with listing conditions or change its control [8]. - Yushan Sports will maintain the increase amount unchanged in case of any corporate actions such as stock splits or dividends during the implementation period [9].

Group 1 - The core point of the announcement is that Yushan Sports, a concerted action party of the controlling shareholder, has increased its stake in Prologis Pharmaceuticals by acquiring 1.6535 million shares, which represents 0.14% of the total share capital, for a total amount of 28.69597 million yuan [1] - Following this acquisition, the combined shareholding of the controlling shareholder and its concerted action parties has reached 52.03%, triggering a change in equity that touches upon the 1% integer multiple [1] - Yushan Sports plans to further increase its stake in the company within six months starting from January 13, with an investment amount not less than 60 million yuan and not exceeding 120 million yuan (including this acquisition) [1] Group 2 - Yushan Sports has committed to not reducing its holdings during the increase period and the statutory period [1] - The planned increase may be subject to market changes, which could result in partial or complete non-implementation of the plan [1]

1月12日，南京银行发布了今年以来首份股东增持公告。公告显示，公司大股东紫金集团及其子公司紫 金信托于2025年9月11日至2026年1月12日期间，以自有资金通过集中竞价交易合计增持南京银行股份 1.23亿股，占该行总股本的1%。此次增持完成后，紫金集团及其一致行动人紫金信托的合计持股比例 由13.02%提升至14.02%，其中紫金集团持股比例增至11.27%，紫金信托持股比例增至2.75%。 在业绩持续增长的同时，南京银行的成本管控效能与资产质量优势也进一步凸显。数据显示，公司前三 季度成本收入比延续下降趋势，保持高效的成本管控水平，不良贷款率稳定在0.83%，与年初持平，资 产质量基础持续夯实；拨备覆盖率为313.22%，风险抵补能力充足。 此次增持并非紫金集团首次加码南京银行。回溯股权变动轨迹，在本次增持周期启动前，紫金集团体系 已完成一轮对南京银行的增持动作。其中，其控股子公司紫金信托于2025年7月18日至9月10日期间，通 过集中竞价交易累计增持5677.98万股，这一操作直接推动紫金集团及其一致行动人合计持股比例从 12.56%攀升至13.02%。 股东的持续增持，与南京银行稳健向好的经营业绩 ...

格隆汇1月13日丨帝欧水华(002798.SZ)公布，公司近日收到持股5%以上股东纾困发展基金出具的《关于 股份变动触及1%整数倍的告知函》。纾困发展基金于2026年1月7日至2026年1月12日，通过深圳证券交 易所交易系统集中竞价的方式增持公司股份3,949,039股，占帝欧水华总股本的0.77%。本次增持后，纾 困发展基金持有公司31,606,076股股份，占公司当前总股本的6.16%，持股变动触及1%的整数倍。 ...

Core Insights - In the past five trading days (January 5 to January 9), 13 companies experienced significant shareholder increases, totaling 33.76 million shares and an aggregate increase amount of 402 million yuan [1] - During the same period, 163 companies had significant shareholder reductions, with a total reduction amount of 15.48 billion yuan [1] Summary by Category Shareholder Increases - Eight companies had increases exceeding 10 million yuan, with Wanrun Co., Ltd. leading at 7.50 million shares and an increase amount of 11.43 million yuan [1] - Tongji Technology followed with an increase of 5.62 million shares and 7.48 million yuan, while Aofei Data ranked third with an increase of 5.45 million yuan [1] - The distribution of increases showed that three companies were from the Growth Enterprise Market (GEM) and nine from the main board, with GEM increases totaling 7.41 million yuan and main board increases at 316 million yuan [1] Market Performance - Stocks with shareholder increases averaged a rise of 7.47% over the past five days, outperforming the Shanghai Composite Index during the same period [1] - Notable gainers included Aofei Data, with a rise of 23.58%, followed by Biological Shares at 15.46% and Hengshi Technology at 13.70% [1] - Conversely, Hengyi Petrochemical and Huamao Logistics experienced declines of 2.60% and 0.82%, respectively [1] Fund Flow - Among the stocks with shareholder increases, eight saw net inflows of main funds, with Biological Shares receiving the highest net inflow of 67 million yuan [2] - The companies with the largest net outflows included Huamao Logistics and Hengshi Technology, with outflows of 40 million yuan and 18 million yuan, respectively [2]

证券日报网讯1月9日，仙坛股份（002746）在互动平台回答投资者提问时表示，公司致力于促进业绩的 持续稳定发展，重视和关注公司价值及股东利益。基于对公司未来持续稳定发展的信心和对公司长期投 资价值的认可，以更好地支持公司未来持续、稳定、健康的发展，公司控股股东的一致行动人山东仙东 控股有限公司，自2023年10月25日开始实施增持计划，截至2025年2月13日已完成全部增持计划，累计 增持6861.32万元。后续如涉及相关计划，公司会依法依规履行决策和信息披露义务。 ...

Core Viewpoint - Junshi Biosciences (688180.SH) announced that its controlling shareholder and chairman, Mr. Xiong Jun, plans to increase his holdings in the company's A-shares and H-shares by at least RMB 100 million over a 12-month period starting from April 12, 2025 [1] Group 1 - Mr. Xiong intends to invest no less than RMB 50 million in A-shares as part of this plan [1] - As of the announcement date, Mr. Xiong has already acquired 100,000 A-shares through the Shanghai Stock Exchange, representing approximately 0.01% of the company's total share capital, with a total transaction amount of RMB 3.8384 million [1] - The share acquisition plan is still in progress, and Mr. Xiong will continue to purchase shares at opportune times during the implementation period [1]

与公司回购形成强力呼应的是，基石投资者也开展增持动作。1月8日，佑驾创新宣布，基石投资者 Horizon Together Holding Ltd.基于对公司业务的长期看好，近期已在公开市场合计购入68.82万股本公司 H股。 据悉，Horizon Together Holding Ltd.为地平线机器人(09660)全资子公司，此次增持源于双方多年的合作 积淀——地平线长期看好佑驾创新未来发展前景，认可其在地平线生态中的重要价值;同时，双方亦期 待通过技术与资源的双向赋能，携手加速L4无人物流车业务的发展进程。 无论是回购迅速落地，还是基石投资者增持，共同构成了佑驾创新"信心背书"体系，向市场清晰传递出 管理层、核心股东及基石投资者对公司长期价值的笃定。 佑驾创新1月7日回购174.54万股H股，总支付金额为2579.94万港元，回购股份占公司已发行股份的 0.527%。 1月8日继续回购125.94万股H股，总支付金额为1907.92万港元。此次回购股份占已发行H股总数的 0.3823%。 智通财经APP获悉，2026年1月8日晚间，佑驾创新(02431)发布公告，截止2026年1月8日，公司于市场累 计 ...

Group 1 - The company, Youjia Innovation, announced the repurchase of 3,004,800 H shares at a total cost of approximately 44,878,604 HKD, with an average price of about 14.94 HKD per share [1] - The board believes that the current trading price of H shares does not reflect their intrinsic value and the actual business prospects of the group, indicating strong confidence in the long-term value of the company [1] - On January 7, the company repurchased 1.7454 million H shares for 25.7994 million HKD, representing 0.527% of the issued shares, followed by a further repurchase of 1.2594 million H shares for 19.0792 million HKD on January 8, accounting for 0.3823% of the total issued H shares [1] Group 2 - Horizon Together Holding Ltd., a wholly-owned subsidiary of Horizon Robotics, has increased its stake in Youjia Innovation by purchasing 688,200 H shares, reflecting a long-term positive outlook on the company's future development [2] - The collaboration between Youjia Innovation and Horizon Robotics is expected to accelerate the development of L4 unmanned logistics vehicles through mutual technological and resource empowerment [2] - The swift share repurchase and the increase in stake by cornerstone investors together form a "confidence endorsement" system, clearly conveying the commitment of management, core shareholders, and cornerstone investors to the company's long-term value [2]

Core Viewpoint - The company Mengbaihe (603313.SH) announced that its controlling shareholder, Mr. Ni Zhanggen, and his concerted party, Mengkang Co., Ltd., have completed their share buyback plan, acquiring a total of 9,585,980 shares, which represents 1.68% of the company's total share capital [1] Summary by Categories Share Buyback Activity - Mengkang Co., Ltd. increased its holdings by 1,431,800 shares through centralized bidding, accounting for 0.25% of the company's total shares, with funding sourced from its own capital [1] - As of the announcement date, the total shares acquired by Mr. Ni Zhanggen and Mengkang Co., Ltd. reached 9,585,980 shares, with a total investment amounting to 80,235,561.93 yuan, exceeding the lower limit of the buyback plan by 0.29% [1]